COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,198 Articles (22,713 medRxiv, 8,485 bioRxiv)

Most recent first Previous |  Page 262: Articles 2611-2620  | Next

Real-World Effectiveness of a Third Dose of mRNA-1273 versus BNT162b2 on Inpatient and Medically Attended COVID-19 among Immunocompromised Adults in the United States
Sun, T., Li, L., Mues, K., Georgieva, M., Kirk, B., Mansi, J., Van de Velde, N., Beck, E.
10.1101/2024.01.30.24302015 — Posted: 2024-01-31
The CoLab-score rapidly and efficiently excludes COVID-19 at the emergency department without need for SARS-CoV-2 testing: a multicenter case-control study
Boer, A.-K., Deneer, R., Maas, M., Ammerlaan, H., van Balkom, R. H. H., Leers, M. P., Martens, R. J. H., Buijs, M. M., Kerremans, J. J., Messchaert, M., van Suijlen, J. D. E., van Riel, N. A. W., Scharnhorst, V.
10.1101/2024.01.30.24301996 — Posted: 2024-01-31
Healthy lifestyle for the prevention of post-COVID-19 multisystem sequelae, hospitalization, and death: a prospective cohort study
Wang, Y., Su, B., Alcalde-Herraiz, M., Barclay, N. L., Tian, Y., Li, C., Wareham, N. J., Paredes, R., Xie, J., PRIETO-ALHAMBRA, D.
10.1101/2024.01.30.24302040 — Posted: 2024-01-31
A novel microporous biomaterial vaccine platform for long-lasting antibody mediated immunity against viral infection.
Mayer, D. P., Nelson, M., Andriyanova, D., Antao, O. Q., Chen, J. S., Scumpia, P. O., Weaver, W. M., Deshayes, S., Weinstein, J. S.
10.1101/2024.01.30.578038 — Posted: 2024-01-31
An isothermal calorimetry assay for determining steady state kinetic and enzyme inhibition parameters for SARS-CoV-2 3CL-protease
Mazzei, L., Ranieri, S., Greene-Cramer, R., Cioffi, C., Montelione, G. T., Ciurli, S.
10.1101/2024.01.31.578159 — Posted: 2024-01-31
Possible roles of phytochemicals with bioactive properties in the prevention of and recovery from COVID-19
Koyama, S., Shields, V. D., Heinbockel, T., Joseph, P. V., Adhikari, P., Kaur, R., Kumar, R., Alizadeh, R., Bhutani, S., Calcinoni, O., Mucignat-Caretta, C., Chen, J., Cooper, K. W., Das, S., Dominguez, P. R., Guardia, M. D., Klyuchnikova, M. A., Laktionova, T. K., MOri, E., Namjoo, Z., Nguyen, H., Ozdener, M. H., Parsa, S., Poyraz, E. O., Strub, D. J., Taghizadeh-Hesary, F., Ueha, R., Voznessenskaya, V. V.
10.1101/2024.01.29.24301882 — Posted: 2024-01-30
Information Bottlenecks in Forecasting COVID-19
Gamarnik, D., Ma, M.
10.1101/2024.01.30.24302003 — Posted: 2024-01-30
Spike N354 glycosylation augments SARS-CoV-2 fitness for human adaptation through multiple mechanisms
Liu, P., Yue, C., Meng, B., Xiao, T., Yang, S., Liu, S., Jian, F., Zhu, Q., Yu, Y., Ren, Y., Wang, P., Li, Y., Wang, J., Mao, X., Shao, F., Wang, Y., Gupta, R. K., Cao, Y., Wang, X.
10.1101/2024.01.29.577677 — Posted: 2024-01-30
Mobility changes following COVID-19 stay-at-home policies varied by socioeconomic measures: An observational study in Ontario, Canada
Wang, S., Wang, L., Baral, S. D., Moloney, G., Johns, J., Huber, C., Mistry, J., Khan, K., Rao, A., Janjua, N., Williamson, T., Katz, A., Ma, H., Maheu-Giroux, M., Kustra, R., Mishra, S.
10.1101/2024.01.29.24301938 — Posted: 2024-01-30
Serological Survey in a university community after the fourth wave of COVID-19 in Senegal
thiam, f., DIOUARA, A. A. M., NDIAYE, C. S. C. A., DIOUF, I., KEBE, K., SENGHOR, A., DJOUMOI, D., MBAYE, M. N., DIOP, I., SANE, S., COUNDOUL, S., TENE, S. D., DIOP, M., DIENG, A. L., NDIAYE, M., SALL, S. M., DIOUF, M., NGUER, C. M.
10.1101/2024.01.28.24301904 — Posted: 2024-01-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).